Limited Competition: HEAL Initiative Resource Centers for the Pain Management Effectiveness Network (ERN) (Clinical Trial Not Allowed)
National Institutes of Health
Classification and identifiers
- Solicitation number
- RFA-TR-26-002
- Assistance listing (CFDA)
- 93.350
Amount
Amount not published by the funder
Who can apply
This a limited competition. Only award recipients funded under RFA-TR-22-012 are eligible to apply.
About this opportunity
The National Center for Advancing Translational Sciences (NCATS), with NINDS, NIA, NIDCR, NCCIH, NCI, NIAMS, NHLBI, NICHD and the NIH Helping to End Addiction Long-term (HEAL) Initiative seeks to advance its mission by renewing the HEAL Pain Management Effectiveness Research Network (ERN) Resource Centers (RCs) needed for the successful planning, implementation, and completion of rigorous large-scale multisite clinical trials (CTs). CTs will expand the suite of evidence-based effective strategies and therapeutics to alleviate pain across the continuum of acute to chronic pain associated with many types of diseases and conditions, or presenting as a disease itself. The RCs will continue the provision of CT operational expertise, clinical coordination and safety monitoring, data coordination...
Related opportunities
- HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)National Institutes of Health
- HEAL Initiative: Limited Competition for the HEALthy Brain and Child Development Study - Research Project Sites (Collaborative U01- Clinical Trial Not Allowed)National Institutes of HealthCloses in 4 days
- HEAL Initiative: Limited Competition for the HEALthy Brain and Child Development (HBCD) Study – Consortium Administrative Core and Data Coordinating Center (U24 Clinical Trial Not Allowed)National Institutes of HealthCloses in 4 days
- Limited Competition: Community-Partnered Nursing Research Centers for Schools and Colleges of Nursing with Limited NIH Funding (P20 Clinical Trial Optional)National Institutes of Health
- HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)National Institutes of HealthCloses Feb 2029
- HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)National Institutes of HealthCloses Feb 2029